Prednisone for Recurrent Implantation Failure With IVF, US Trends in Youth Mental Health ED Visits, USPSTF Recommendation on Screening for Latent TB, and more
Editor’s Summary by Karen Lasser, MD, Senior Editor of JAMA, for the May 2, 2023, issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - May 2, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Alliance A031201 - A phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for metastatic castration resistant prostate cancer (mCRPC)
Dr. Celestia Higano, MD of the University of Washington discusses the Alliance A031201 a phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for metastatic...
Author: Annual-Meeting
Added: 06/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2019 Category: Cancer & Oncology Source Type: podcasts
Subcutaneous daratumumab: an update on the latest MM clinical trials
Previous clinical trial investigations have established that daratumumab plus bortezomib, melphalan and prednisone, also known as dara+VMP, is significantly more effective than VMP alone in terms of r...
Author: VJHemOnc
Added: 07/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 24, 2018 Category: Cancer & Oncology Source Type: podcasts
Adding to Lenalidomide to Make it Work Better Prednisone inhibitors, carfilzomib, and bortezomib
Paul G. Richardson, MD, explains Adding to Lenalidomide to Make it Work Better Prednisone inhibitors, carfilzomib, and bortezomib at Imedex Great Debates 2018.
Author: hematologydebates
Added: 05/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 10, 2018 Category: Cancer & Oncology Source Type: podcasts
PEP-C for treatment of relapsed lymphoma
The treatment of relapsed/refractory lymphoma can prove to be challenging. PEP-C (prednisone, etoposide, procarbazine, and cyclophosphamide) is an oral combination therapy regimen used for such patien...
Author: VJHemOnc
Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Vs VMP in NDMM Pts (ALCYONE)
Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) ...
Author: InternationalMyelomaFoundation
Added: 01/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 16, 2018 Category: Cancer & Oncology Source Type: podcasts
New Data Change Metastatic Prostate Cancer Treatment Paradigm
Dr Chodak reviews results of the LATITUDE trial, which compared ADT alone versus ADT with abiraterone acetate plus prednisone. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - August 14, 2017 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
Evaluation of response to enzalutamide consecutively after disease progression on abiraterone prednisone
Dr. Petros Grivas, MD at Cleveland Clinic discusses the evaluation of response to enzalutamide consecutively after disease progression on abiraterone prednisone at ASCO GU 2016 in San Francisco.
Author: 2016_Genitourinary
Added: 01/08/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 8, 2016 Category: Cancer & Oncology Source Type: podcasts
ASCO 2014: Treatment of RRMM with weekly CyBor-P/D
Donna Reece, MD
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Treatment of relapsed/refractory multiple myeloma with weekly cyclophosphamide plus bortezomib plus prednisone or dexameth...
Author: InternationalMyelomaFoundation
Added: 09/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 11, 2015 Category: Cancer & Oncology Source Type: podcasts
ASCO2014: A Phase III trial Comparing MPT versus MPR In Newly Diagnosed Multiple Myeloma
Keith K. Stewart, MB ChB
Mayo Clinic
Scottsdale, Arizona, USA
E1A06: A phase III trial comparing melphalan, prednisone, and thalidomide (MPT) versus melphalan, prednisone, and lenalidomide (MPR) ...
Author: InternationalMyelomaFoundation
Added: 09/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 10, 2015 Category: Cancer & Oncology Source Type: podcasts
IMAAGEN: Phase 2 trial of abiraterone acetate plus prednisone for advanced prostate cancer | Dr Neal Shore at ASCO 2015
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Neal Shore, MD, FACS, of Atlantic Urology Clinics, Myrtle Beach, SC, provides an update on IMAAGEN, a multicentre, open-label, ...
Author: EMJ
Added: 08/26/2015 (Source: Oncology Tube)
Source: Oncology Tube - August 26, 2015 Category: Cancer & Oncology Source Type: podcasts
Approval and Use of Abiraterone
Data related to the use of abiraterone in the first-line setting, as well as data from studies examining the concurrent use of abiraterone and prednisone.
Daniel P. Petrylak, MD,
Author: onclivetv
Added: 03/30/2015 (Source: Oncology Tube)
Source: Oncology Tube - March 30, 2015 Category: Cancer & Oncology Source Type: podcasts
Dr. Scholz discusses the use of Abiraterone in mCRPC
Dr. Scholz discusses the final analysis of the COU-AA-302 study, which compared abiraterone acetate to prednisone alone in patients with metastatic castration-resistant prostate cancer (mCRPC).
Mark ...
Author: onclivetv
Added: 03/04/2015 (Source: Oncology Tube)
Source: Oncology Tube - March 4, 2015 Category: Cancer & Oncology Source Type: podcasts
